drugset / Trial / NCT06294990

Klinefelter Syndrome and Testosterone Treatment in Puberty

NCT06294990

Phase 4 Recruiting 32 enrolled Lise Aksglæde
RandomizedParallel-groupTriple-blindTreatment

Summary

The goal of this randomized clinical trial is to study the effect of testosterone replacement therapy during puberty in boys with Klinefelter syndrome (KS, 47,XXY). The main questions to answer are how treatment with testosterone will affect body fat mass, lipid and glucose metabolism, growth and body proportions, bone mineralization as well as effects on neurocognitive development and emotional and social difficulties. Participants will be randomized to two years treatment with testosterone or placebo.

Timeline

Start
2024-08-15
Primary completion
2029-12-31
Completion
2029-12-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Testosterone Small molecule Topical

Indications